Position in ORKA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$449,772
New position
Shares Held
4,726
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#176
of 254 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 24%
Shared 76%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIRTUS ADVISERS, LLC holds $9,287,940 across 18 Biotechnology names. ORKA ranks #10 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
44,384 | $1,122,914 | |
| 2 | HRMY |
Harmony Biosciences Holdings, Inc.
|
29,253 | $1,065,101 | |
| 3 | EXEL |
Exelixis, Inc.
|
14,769 | $803,581 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
9,249 | $753,885 | |
| 5 | INVA |
Innoviva, Inc.
|
30,614 | $695,243 | |
| 6 | VCEL |
Vericel Corp
|
15,570 | $692,709 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
18,007 | $637,267 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
27,098 | $486,950 |
All Filings in ORKA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $449,772 | 4,726 | Shares | Other | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||